dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cuyàs, Elisabet |
dc.contributor.author | Fernández-Arroyo, Salvador |
dc.contributor.author | Buxó, Maria |
dc.contributor.author | Pernas, Sonia |
dc.contributor.author | Dorca, Joan |
dc.contributor.author | Álvarez, Isabel |
dc.contributor.author | Cortés Castan, Javier |
dc.date.accessioned | 2021-03-23T14:30:14Z |
dc.date.available | 2021-03-23T14:30:14Z |
dc.date.issued | 2019-05-15 |
dc.identifier.citation | Cuyàs E, Fernández-Arroyo S, Buxó M, Pernas S, Dorca J, Álvarez I, et al. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients. Aging (Albany NY). 2019 May 15;11(9):2874–88. |
dc.identifier.issn | 1945-4589 |
dc.identifier.uri | https://hdl.handle.net/11351/5789 |
dc.description | Homocisteïna; Càncer de mama; Dieta cetogènica |
dc.description.sponsorship | This work was supported by grants from the Ministerio de Sanidad, Servicios Sociales e Igualdad (EC10-125, Ayudas para el Fomento de la Investigación Clínica Independiente to Begoña Martin-Castillo). Work in the Menendez laboratory is supported by the Ministerio de Ciencia e Innovación (Grant SAF2016-80639-P, Plan Nacional de l+D+I, founded by the European Regional Development Fund [EU FEDER], Spain) and by an unrestricted research grant from the Fundació Oncolliga Girona (Lliga catalana d’ajuda al malalt de càncer, Girona). |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation.ispartofseries | Aging;11(9) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Metabolisme |
dc.subject | Metformina |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /metabolism |
dc.subject.mesh | Metformin |
dc.title | Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.18632/aging.101960 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /metabolismo |
dc.subject.decs | metformina |
dc.relation.publishversion | https://www.aging-us.com/article/101960/text |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Cuyàs E] Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain. Girona Biomedical Research Institute (IDIBGI), Girona, Spain. [Fernández-Arroyo S] Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain. [Buxó M] Girona Biomedical Research Institute (IDIBGI), Girona, Spain. [Pernas S] Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain. [Dorca J] Medical Oncology, Catalan Institute of Oncology, Girona, Spain. [Álvarez I] Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain. Biodonostia Health Research Institute, Donostia-San Sebastián, Spain. [Cortés J] IOB Institute of Oncology, Hospital Quirónsalud, Madrid and Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 31076561 |
dc.identifier.wos | 000468332900024 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2016-80639-P |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |